🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Celebration of life today ⁦MD Anderson Cancer Center⁩ for Cullen Taniguchi. Amazing legacy as a physician and scientist but greatest impact will be on the trainees he mentored. #radonc #endcancer ⁦Percy Lee MD⁩ ⁦Anirban Maitra⁩ ⁦Prajnan Das, MD, MS, MPH⁩

Yesterday we celebrated the life of the one and only Cullen Taniguchi, MD. It was filled with laughter, tears, and hope. Jae Phan put together this touching video to commemorate Cullen's spirit. Albert Koong, MD PhD Prajnan Das, MD, MS, MPH Anirban Maitra You can find it here: vimeo.com/909485992

During this scene in 'Interstellar', you can hear a ticking noise on the soundtrack every 1.25 seconds. Each tick represents a day passing on Earth. MIND=BLOWN😱

Out now in IJROBP - The Red Journal, my piece with Robert Timmerman describing a new way to approach radiation toxicity that we term as CUT: calculated useful trauma. sciencedirect.com/science/articl…

Nikola Tesla claimed to never sleep more than two hours per night. He also had an intense fear of pearls, to the extent that he refused to speak to women wearing them.

Thrilled to share our latest study in Nature Cancer investigating the diverse malignant and stromal cell states that make up soft tissue #sarcomas (STS) and their associations with patient outcomes and response to treatment! 1/12 nature.com/articles/s4301…

Daniel Kahneman passed away today He changed the world of behavioral finance Here are 10 things I learned from his book Thinking Fast and Slow as a way to say thank you:

A sad day Danny Kahneman, 1934-2024 Most people knew him as a thinker. I knew him as a person.

When Albert Einstein met Charlie Chaplin in 1931, Einstein said, "What I admire most about your art is its universality. You do not say a word, and yet the world understands you." "It's true." Replied Chaplin, "But your fame is even greater. The world admires you, when no one

📢New Paper Alert! Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall Survival Estimates The BMJ Alexander Sherry Pavlos Msaouel Joseph Abi Jaoude Ramez Kouzy, MD MD Anderson Cancer Center Summary by Amalya Sargsyan oncodaily.com/49339.html

Thinking, Fast and Slow is the best Behavioral Finance book ever. Here are 10 things I learned from the book:

It is with great sadness that we share the news of Dr. Wu Liu's passing on May 14th. He was an incredible clinical physicist and steadfast researcher, an inspiring colleague, and a great friend who will be dearly missed.

Same director, all bangers.

Last ATB ARRO collab episode of the AY! Tune in to learn about CNS tumors with Jie Jane Chen, MD (PGY4 UCSF), Adam Beighley (PGY3 KP), and Joseph Abi Jaoude (PGY2 Stanford). Thanks to Dr. El Rahimy for leading the episode! 🧠

Our new research highlights patient-level savings using the Mark Cuban Cost Plus Drug Company (MCCPDC) for purchasing generic drugs! This is the first study to quantify individual out-of-pocket savings by opting for MCCPDC over traditional insurance. jamanetwork.com/journals/jama-…

We are excited to announce that radiation oncology resident Wilson Mai, MD, PhD, has received the 2024-2025 ASTRO-Lungevity Grant for his proposed project “Exploiting Dependencies Created by KEAP1/NFE2L2 Mutations in NSCLC to Overcome Radiation Resistance" from the ASTRO Board.

Incredible work led by James WS Jahng, PhD exploring ionizing radiation impacts on the cardiovascular system, drawing from nuclear accidents, occupational exposure, and cancer therapy. Providing insights to enhance personalized risk assessments and management strategies to mitigate long

The essence of freedom of expression lies in its unconditionality. (Most of those asking for it don't realize that they are just trying to promote their side.)

Multivariable analyses for strong prognostic factors, even in randomized trials, can boost statistical power. Here, we find that favorable power gains from MVA meaningfully translate to improved odds of meeting the primary endpoints of oncology phase III randomized trials.